Insulin Continues to Induce Plasminogen Activator Inhibitor 1 Gene Expression in Insulin-Resistant Mice and Adipocytes

Molecular Medicine

Volumn 6, Issue 8, 2000, Pages 680-692

  Samad, Fahumiya ^a   Pandey, Manjula ^a   Bell, Philip A ^b   Loskutoff, David J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adipocytes; General Cardiovascular Risk; Insulin mediated Glucose Transport; Metabolic Insulin Resistance; Non insulin dependent Diabetes Mellitus (NIDDM)

Indexed keywords

DEOXYGLUCOSE; INSULIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOCYTE; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CARDIOVASCULAR DISEASE; CELL LINE; DRUG EFFECT; GENETICS; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; IN SITU HYBRIDIZATION; INSULIN RESISTANCE; METABOLISM; MOUSE; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL; UPREGULATION;

ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CELL LINE; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; HYPERINSULINISM; IN SITU HYBRIDIZATION; INSULIN; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

MLCS; MLOWN;

EID: 0034252457     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03402048     Document Type: Article

References (50)

1. N. Finer Obesity Brit. Med. Bull. 1997 53 229 450 10.1093/oxfordjournals.bmb.a011620
2. J.B. McGill D.J. Schneider C.L. Arfken C.L. Lucore B.E. Sobel Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients Diabetes 1994 43 104 109 10.2337/diab.43.1.104 1:STN:280:DyaK2c%2FosFKqsA%3D%3D 8262307
3. B.J. van Potter Loon C. Kluft J.K. Radder M.A. Blankenstein A.E. Meinders The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance Metabolism 1993 42 945 949 10.1016/0026-0495(93)90005-9
4. P. Vague I. Juhan-Vague V. Chabert M.C. Alessi C. Atlan Fat distribution and plasmino-gen activator inhibitor activity in nondiabetic obese women Metabolism 1989 38 913 915 10.1016/0026-0495(89)90241-2 1:STN:280:DyaL1MzmsVarsQ%3D%3D 2505018
5. C. Fearns F. Samad D.J. Loskutoff V.W.M. van Hinsbergh Synthesis and localization of PAI-1 in the vessel wall Vascular Control of Hemostasis 1995 Amsterdam Harwood Academic Publishers 207 226 Vol. 1
6. M.S. Sawdey D.J. Loskutoff Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β J. Clin. Invest 1991 88 1346 1353 10.1172/JCI115440 1:CAS:528:DyaK3MXmtlSiur0%3D 1918385 295605
7. F. Samad D.J. Loskutoff Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice Mol. Med. 1996 2 568 582 10.1007/BF03401641 1:CAS:528:DyaK28XmslKqtrs%3D 8898373 2230189
8. F. Samad K. Yamamoto D.J. Loskutoff Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: induction by tumor necrosis factor-α and lipopolysaccharide J. Clin. Invest. 1996 97 37 46 10.1172/JCI118404 1:CAS:528:DyaK28Xhtlajurw%3D 8550848 507060
9. I. Shimomura T. Funahashi M. Takahashi et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Nature Med. 1996 2 800 803 10.1038/nm0796-800 1:CAS:528:DyaK28XjvF2isrg%3D 8673927
10. M.C. Alessi F. Peiretti P. Morange M. Henry G. Nalbone I. Juhan-Vague Production of plas-minogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease Diabetes 1997 46 860 867 10.2337/diab.46.5.860 1:CAS:528:DyaK2sXjtVGntb0%3D 9133556
11. I. Juhan-Vague M.C. Alessi PAI-1, obesity, insulin resistance and risk of cardiovascular events Thromb. Haemost. 1997 78 656 660 10.1055/s-0038-1657607 1:CAS:528:DyaK2sXktFelu7s%3D 9198234
12. M. Medvescek D. Keber M. Stegnar A. Borovnicar Plasminogen activator inhibitor 1 response to a carbohydrate meal in obese subjects Fibrinolysis 1990 4 suppl 2 89 90 10.1016/0268-9499(90)90371-P 1:CAS:528:DyaK3MXlt1Gm
13. D.A. Ehrmann D.J. Schneider B.E. Sobel et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 1997 82 2108 2116 9215280 1:CAS:528:DyaK2sXksVCntrY%3D
14. P.H. Vague I. Juhan-Vague M.C. Alessi C. Badier J. Valadier Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects Thromb. Haemost. 1987 58 326 328
15. T.K. Nordt H. Sawa S. Fujii B.E. Sobel Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo Circulation 1995 91 764 770 10.1161/01.CIR.91.3.764 1:CAS:528:DyaK2MXktFOitLk%3D 7828304
16. F. Carmassi M. Morale L. Ferrini et al. Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects Am. J. Med. 1999 107 344 350 10.1016/S0002-9343(99)00240-5 1:CAS:528:DyaK1MXnt1Sktr8%3D 10527036
17. T.K. Nordt D.J. Schneider B.E. Sobel Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin: a potential risk factor for vascular disease Circulation 1994 89 321 330 10.1161/01.CIR.89.1.321 1:CAS:528:DyaK2cXksFCqurk%3D 8281664
18. M.C. Alessi F. Anfosso M. Henry F. Peiretti G. Nalbone I. Juhan-Vague Up-regulation of PAI-1 synthesis by insulin and proinsulin in HEP G2 cells but not in endothelial cells Fibrinolysis 1995 9 237 242 10.1016/S0268-9499(08)80065-3 1:CAS:528:DyaK2MXnvVCltbw%3D
19. P.-E. Morange J. Aubert F. Pieretti et al. Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue Diabetes 1999 48 890 895 10.2337/diabetes.48.4.890 1:CAS:528:DyaK1MXitFCqtb8%3D 10102708
20. R.R. Schleef M. Sinha D.J. Loskutoff Im-munoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator J. Lab. Clin. Med. 1985 106 408 415 3930637 1:CAS:528:DyaL2MXlvFWqsr8%3D
21. F. Samad K. Yamamoto M. Pandey D. Loskutoff Elevated expression of transforming growth factor-β in adipose tissue from obese mice Mol. Med. 1997 3 37 48 10.1007/BF03401666 1:CAS:528:DyaK2sXitValt74%3D 9132278 2230108
22. H. Green O. Kehinde An established preadipose cell line and its differentiation in culture: II. Factors affecting the adipose conversion Cell 1975 5 19 27 10.1016/0092-8674(75)90087-2 1:CAS:528:DyaE2MXlt12gu7o%3D 165899
23. B.M. Clancy M.P. Czech Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes J. Biol. Chem. 1990 265 12434 12443 2165064 1:CAS:528:DyaK3cXkvFGhs7c%3D
24. M. Rodbell Metabolism of isolated fat cells: I. Effects of hormones on glucose metabolism and lipolysis J. Biol. Chem. 1964 239 375 380 14169133 1:CAS:528:DyaF2cXjt1GhsQ%3D%3D
25. E.A. Jaffe R.L. Nachman C.G. Becker C.R. Minick Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria J. Clin. Invest. 1973 52 2745 2756 10.1172/JCI107470 1:STN:280:DyaE2c%2FitFKgug%3D%3D 4355998 302542
26. K. Yamamoto V. de Waard C. Fearns D.J. Loskutoff Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo Blood 1998 92 2791 2801 9763564 1:CAS:528:DyaK1cXms1eltLo%3D
27. G.S. Hotamisligil N.S. Shargill B.M. Spiegelman Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Science 1993 259 87 91 10.1126/science.7678183 1:CAS:528:DyaK3sXnvFaitw%3D%3D 7678183
28. B. Cheatham C.R. Kahn Insulin action and the insulin signaling network Endocr. Rev. 1995 16 117 142 7781591 1:CAS:528:DyaK2MXmtFWisrw%3D
29. K. Kotani A.J. Carozzi H. Sakaue et al. Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes Biochem. Biophys. Res. Comm. 1995 209 343 348 10.1006/bbrc.1995.1509 1:CAS:528:DyaK2MXkvFyjs7k%3D 7726855
30. S.F. Hausdorff D.C. Fingar K. Morioka et al. Identification of wortmannin-sensitive targets in 3T3-L1 adipocytes. Dissociation of insulin-stimulated glucose uptake and GLUT4 translocation J. Biol. Chem. 1999 274 24677 24684 10.1074/jbc.274.35.24677 1:CAS:528:DyaK1MXls1yntb4%3D 10455135
31. F. Samad K.T. Uysal S.M. Wiesbrock M. Pandey G.S. Hotamisligil D.J. Loskutoff Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibi-tor-1 Proc. Natl. Acad. Sci. U. S. A. 1999 96 6902 6907 10.1073/pnas.96.12.6902 1:CAS:528:DyaK1MXks1WktrY%3D 10359811 22014
32. Y.Q. Chen M. Su R.R. Walia Q. Hao J.W. Covington D.E. Vaughan Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells J. Biol. Chem. 1998 273 8225 8231 10.1074/jbc.273.14.8225 1:CAS:528:DyaK1cXitlOisb8%3D 9525928
33. R.M. O’Brien D.K. Granner Regulation of gene expression by insulin Physiol. Rev. 1996 76 1109 1161 10.1152/physrev.1996.76.4.1109 8874496
34. O.A. MacDougald C.-S. Hwang H. Fan M.D. Lane Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes Proc. Natl. Acad. Sci. U. S. A. 1995 92 9034 9037 10.1073/pnas.92.20.9034 1:CAS:528:DyaK2MXosVWls7g%3D 7568067 40918
35. J.M. Bryson J.L. Phuyal D.R. Proctor S.C. Blair I.D. Caterson G.J. Cooney Plasma insulin rise precedes rise in ob mRNA expression and plasma leptin in gold thioglucose-obese mice Am. J. Physiol. Endocrinol. Metab. 1999 39 E358 E364 10.1152/ajpendo.1999.276.2.E358
36. V. De Mitrio G. De Pergola R. Vettor et al. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in pre-menopausal women Metabolism 1999 48 960 964 10.1016/S0026-0495(99)90190-7 10459558
37. J.L. Evans C.M. Honer B.E. Womelsdorf E.L. Kaplan P.A. Bell The effects of wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis Cell. Signal. 1995 7 365 376 10.1016/0898-6568(95)00007-C 1:CAS:528:DyaK2MXnt1Okt7o%3D 8527305
38. S.S. Martin T. Haruta A.J. Morris A. Klippel L.T. Williams J.M. Olefsky Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes J. Biol. Chem. 1996 271 17605 17608 10.1074/jbc.271.30.17605 1:CAS:528:DyaK28XksFyisL8%3D 8663595
39. R.L. Bradley B. Cheatham Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes Diabetes 1999 48 272 278 10.2337/diabetes.48.2.272 1:CAS:528:DyaK1MXpsFKnsQ%3D%3D 10334301
40. S.K. Moule R.M. Denton Multiple signaling pathways involved in the metabolic effects of insulin Am. J. Cardiol. 1997 80 41A 49A 10.1016/S0002-9149(97)00457-8 1:CAS:528:DyaK2sXmtFWisb0%3D 9293955
41. S. Harada R.M. Smith J.A. Smith M.F. White L. Jarett Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidyli-nositol 3-kinase activation J. Biol. Chem. 1996 271 30222 30226 10.1074/jbc.271.47.30222 1:CAS:528:DyaK28XntFOnsLo%3D 8939974
42. G.C. Prendergast L.E. Diamond D. Dahl M.D. Cole The c-myc-regulated gene mr1 encodes plasminogen activator inhibitor 1 Mol. Cell. Biol. 1990 10 1265 1269 10.1128/MCB.10.3.1265 1:CAS:528:DyaK3cXkvFahu7c%3D 2406566 361018
43. H. Osawa C. Sutherland R.B. Robey R.L. Printz D.K. Granner Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin J. Biol. Chem. 1996 271 16690 16694 10.1074/jbc.271.28.16690 1:CAS:528:DyaK28Xkt1Cjs7o%3D 8663315
44. J.W. Leitner T. Kline K. Carel M. Goalstone B. Draznin Hyperinsulinemia potentiates activation of p21Ras by growth factors Endocrinol. 1997 138 2211 2214 10.1210/endo.138.5.5240 1:STN:280:DyaK2s3ms1Krsw%3D%3D
45. D.J. Loskutoff F. Samad The adipocyte and hemostatic balance in obesity: Studies of PAI-1 Arterioscler. Thromb. Vasc. Biol. 1998 18 1 6 10.1161/01.ATV.18.1.1 1:CAS:528:DyaK1cXptVKjuw%3D%3D 9445248
46. C.M. Halleux P.J. Deckerck S.L. Tran R. Detry S.M. Brichard Hormonal control of plas-minogen activator inhibitor-1 gene expression and production in adipose tissue: stimulation by glucocorticoids and inhibition by cathe-cholamines J. Clin. Endocrinol. Metab. 1999 84 4097 4105 10566656 1:CAS:528:DyaK1MXntlOqur0%3D
47. J.N. Livingston K.M. Lerea J. Bolinder L. Kager L. Backman P. Arner Binding and molecular weight properties of the insulin receptor for omental and subcutaneous adipocytes in human obesity Diabetologia 1984 27 447 453 10.1007/BF00273909 1:CAS:528:DyaL2MXhvVWgtw%3D%3D 6391988
48. J.W. Kolaczynski M.R. Nyce R.V. Considine et al. Acute and chronic effect of insulin in lep-tin production in humans: studies in vivo and in vitro Diabetes 1996 45 699 701 10.2337/diab.45.5.699 1:CAS:528:DyaK28Xjs1yltr4%3D 8621027
49. P. Leroy S. Dessolin P. Villageois et al. Expression of ob gene in adipose cells: regulation by insulin J. Biol. Chem. 1996 271 2365 2368 10.1074/jbc.271.5.2365 1:CAS:528:DyaK28XptVKnsw%3D%3D 8576190
50. M. Wabitsch P.B. Jensen W.F. Blum et al. Insulin and cortisol promote leptin production in cultured human fat cells Diabetes 1996 45 1435 1438 10.2337/diab.45.10.1435 1:CAS:528:DyaK28XmtFCnt7o%3D 8826983